Business Wire (Mon, 4:01PM)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
2,088 people get COV articles and Market Currents by email alert.
Get email alerts on COV »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Mon, 9:00AM)
-
Covidien Aiming For Mallinckrodt Spin-OutEP Vantage • Wed, May 8 -
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 3, 2013)
-
-
At These Levels, Covidien Has Room To RunStephen Barnes • Tue, Apr 30 -
-
Business Wire (Apr 26, 2013)
-
-
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 15, 2013)
-
Business Wire (Apr 11, 2013)
-
-
To learn more about Seeking Alpha Pro, click here.
-
Covidien Aiming For Mallinckrodt Spin-OutEP Vantage • Wed, May 8
-
At These Levels, Covidien Has Room To RunStephen Barnes • Tue, Apr 30
-
-
-
-
Covidien - A Leading Growth Story At A Reasonable PriceStephen Simpson • Thu, Jul 26, 2012
-
Covidien: Earnings PreviewZacks Investment Research • Mon, Jul 23, 2012 -
-
-
Covidien Plays To Its Strengths And Still Looks UndervaluedStephen Simpson • Fri, Jan 27, 2012
-
Why Covidien Will Surge 50% As Hospira StrugglesTakeover Analyst • Fri, Jan 20, 2012 -
The Search For Rising Dividends: Covidien PLCK202 • Tue, Jan 10, 2012 -
Covidien: Earnings PreviewZacks Investment Research • Mon, Nov 14, 2011
-
Covidien: Defensive Stock Pick With Strong Technical SupportBret Jensen • Sun, Oct 16, 2011 -
Covidien Gets FDA NodZacks Investment Research • Fri, Mar 11, 2011
-
-
Covidien Backs FDA Safety WarningZacks Investment Research • Tue, Sep 14, 2010
-
-
-
-
-
-
-
CareFusion On The Right PathStephen Simpson • Wed, Apr 3
-
-
-
-
-
-
-
-
-
-
3 Stocks With Recent Intensive Insider SellingMarkus Aarnio • Sun, Feb 24 -
-
-
-
Covidien's CEO Discusses F4Q 2012 Results - Earnings Call TranscriptFri, Nov 9, 2012
-
Covidien Management Discusses Q3 2012 Results - Earnings Call TranscriptThu, Jul 26, 2012
-
Covidien's CEO Discusses Q2 2012 Results - Earnings Call TranscriptFri, Apr 27, 2012
-
Covidien plc's CEO Discusses Q1 2012 Results - Earnings Call TranscriptThu, Jan 26, 2012 • 1 Comment
-
Covidien plc - Shareholder/Analyst CallThu, Dec 15, 2011
-
Covidien plc - Analyst/Investor DayThu, Sep 8, 2011
-
Covidien plc's CEO Discusses Q2 2011 Results - Earnings Call TranscriptThu, Apr 21, 2011
-
Covidien CEO Discusses Q1 2011 Results - Earnings Call TranscriptTue, Feb 1, 2011
-
Covidien CEO Discusses F4Q10 Results - Earnings Call TranscriptTue, Nov 9, 2010
-
Covidien Ltd. F3Q10 (Qtr End 6/30/10 Earnings Call TranscriptThu, Jul 29, 2010
-
Covidien Ltd. F2Q10 (Qtr End 03/26/10) Earnings Call TranscriptWed, Apr 21, 2010
-
at CNBC.com (Fri, 6:02PM)
-
Business Wire (Mon, 4:01PM)
-
Business Wire (Mon, 9:00AM)
-
Business Wire (May 8, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (May 3, 2013)
-
at MarketWatch.com (Apr 26, 2013)
-
Business Wire (Apr 26, 2013)
-
Business Wire (Apr 17, 2013)
-
Business Wire (Apr 15, 2013)
-
Business Wire (Apr 11, 2013)
-
Business Wire (Mar 29, 2013)
-
Business Wire (Mar 25, 2013)
-
Business Wire (Mar 21, 2013)
-
Business Wire (Mar 20, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 14, 2013)
-
Business Wire (Mar 13, 2013)
-
Business Wire (Mar 7, 2013)
COV vs. ETF Alternatives
Company Description
We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presence in non-U.S. markets. Our mission is to create and... More
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Friday, May 3, 5:17 PM Covidien (COV) reduces its FY13 net sales guidance and adjusts its financial statements for the past three years to refect the impending spinoff of its Malinckrodt business. The company now estimates that net sales in FY13 will be up 4% to 5%, which corresponds to about $12.32B to $12.44B, down from its prior projection of 5% to 8% growth. It expects Mallinckrodt to see sales growth of between 7% to 11% for the fiscal year ending September 27. Shares -0.5% AH. Comment! [Global & FX, Healthcare, Earnings]
- Friday, April 26, 6:01 AM Covidien (COV): FQ2 EPS of $1.12 beats by $0.03. Revenue of $3.10B (+5% Y/Y) misses by $0.02B. (PR) Comment! [Earnings, Breaking News, Healthcare]
- Friday, April 26, 12:05 AM Notable earnings before Friday’s open: ABBV, AEP, AON, ARLP, B, BKW, BPO, COV, CVX, DHI, DLR, DTE, FLIR, GDI, GNC, GT, HMSY, IMGN, ITRI, LAZ, LYB, MPW, NOV, SPG, TRP, TYC, VFC, VTR, WETF, WY Comment! [Earnings]
- Thursday, April 25, 5:30 PM Notable earnings before Friday’s open: ABBV, AEP, AON, ARLP, B, BKW, BPO, COV, CVX, DHI, DLR, DTE, FLIR, GDI, GNC, GT, HMSY, IMGN, ITRI, LAZ, LYB, MPW, NOV, SPG, TRP, TYC, VFC, VTR, WETF, WY Comment! [Earnings]
- Friday, January 25, 2:04 PM Covidien (COV +0.4%) gives back much of its early morning pop after its FQ1 beat expectations across the board. Net profit actually declined 0.2% Y/Y however as costs to split the health-care products company masked improving sales. Sales in its medical-devices business, its largest by revenue, rose 7.6% to $ 2.13B. Medical-supplies sales increased 2.4% to $434M, while pharmaceuticals sales declined 0.2% to $489M. It also ups FY13 guidance, now seeing revenue growth of 5% to 8%, which is 2 percentage points above prior guidance. Comment! [Healthcare, Earnings]
- Friday, January 25, 6:01 AM Covidien (COV): FQ1 EPS of $1.1 beats by $0.04. Revenue of $3.06B (+5% Y/Y) beats by $0.06B. (PR) Comment! [Earnings, Healthcare, Breaking News]
- Friday, January 25, 12:05 AM Notable earnings before Friday’s open: AEP, COV, HAL, HON, IMGN, KMB, OSK, PG, WY Comment! [Earnings]
- Thursday, January 24, 5:30 PM Notable earnings before Friday’s open: AEP, COV, HAL, HON, IMGN, KMB, OSK, PG, WY Comment! [Earnings]
- Friday, November 9, 2012, 6:10 AM Covidien (COV): FQ4 EPS of $1.02 beats by $0.02. Revenue of $3B (-3% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
- Friday, November 9, 2012, 12:05 AM Notable earnings before Friday’s open: AEE, BAM, COV, FWLT, JCP, LNT, MEA, MHR, MTG, NPSP, VTG, WCRX, XTEX Comment! [Earnings]
- Thursday, November 8, 2012, 5:30 PM Notable earnings before Friday’s open: AEE, BAM, COV, FWLT, JCP, LNT, MEA, MHR, MTG, NPSP, VTG, WCRX, XTEX Comment! [Earnings]
- Thursday, July 26, 2012, 2:00 PM Covidien (COV +4.4%) is trading higher today after beating FQ3 bottom-line estimates by a penny. Sales gained 2.8% to $3.01B, which was in line with consensus, but net earnings fell by 15% Y/Y as the maker of operating-room gear and other medical products deals with challenging conditions in Europe. 1 Comment [Global & FX, Earnings, On the Move, Healthcare]
- Thursday, July 26, 2012, 6:14 AM Covidien (COV): FQ3 EPS of $1.07 beats by $0.01. Revenue of $3.01B (+2.8% Y/Y) in line. (PR) Comment! [Earnings, Healthcare]
- Thursday, July 26, 2012, 12:05 AM Notable earnings before Thursday’s open: ABB, ABC, ABX, AGCO, ALKS, ALU, AMLN, AZN, BC, BMS, BSX, BWA, CAM, CELG, CL, CME, CMS, CNX, COV, DAN, DDD, DNKN, DOW, DPS, EQT, ESV, FLIR, FNP, GG, GNC, GTI, HOT, HSY, IMAX, IP, IPG, IRM, IVZ, JNS, KMB, LINE, MCO, MHP, MJN, MMM, MYL, NBL, NEE, NOV, ORI, OXY, PCP, PCS, PHM, PLD, POT, PTEN, RCL, RTN, S, TKR, UAL, UTX, VTR, WEC, WM, WPI, XOM, ZMH Comment! [Earnings]
- Wednesday, July 25, 2012, 5:30 PM Notable earnings before Thursday’s open: ABB, ABC, ABX, AGCO, ALKS, ALU, AMLN, AZN, BC, BMS, BSX, BWA, CAM, CELG, CL, CME, CMS, CNX, COV, DAN, DDD, DNKN, DOW, DPS, EQT, ESV, FLIR, FNP, GG, GNC, GTI, HOT, HSY, IMAX, IP, IPG, IRM, IVZ, JNS, KMB, LINE, MCO, MHP, MJN, MMM, MYL, NBL, NEE, NOV, ORI, OXY, PCP, PCS, PHM, PLD, POT, PTEN, RCL, RTN, S, TKR, UAL, UTX, VTR, WEC, WM, WPI, XOM, ZMH Comment! [Earnings]
- Friday, April 27, 2012, 6:31 AM Covidien (COV): FQ2 EPS of $1.05 beats by $0.02. Revenue of $2.95B (+5.2% Y/Y) in-line. (PR) Comment! [Earnings, Healthcare]
-
- View all 0 replies
-
- View all 0 replies
-
neobliviscar
Anyone else looking at bottom ticking the bleeders $COV and $BLL ? Where would you get in? - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
$LSE $ABM and $BBD are tomorrow's best yielding ex-dividend stocks - http://stks.co/dOtj - 12 shares with 3.09% average yield $COV - View all 0 replies
-
- View all 0 replies
-
Dividend Sheet
$NGG $SNY and $CS are the best yielding stocks with buy or better rating from Europe + http://stks.co/eJcR + I like $NVO $BUD and $COV - View all 0 replies
-
- View all 4 replies
-
-
Dr. Kris: Bob: I'm dubbing you the official SA music director. Each stock should have its own theme song.
-
Dividend Sheet
$HLF $SNY and $COV are the best yielding stocks from the top 20 buy rated healthcare stocks + http://stks.co/cHAs + I also like $NVO $COO - View all 0 replies
-
- View all 0 replies
LATEST REPLIES
-
- View all 4 replies
-
-
Dr. Kris: Bob: I'm dubbing you the official SA music director. Each stock should have its own theme song.
-
- View all 3 replies
-
FortSumter: Sorry, my background was more large scale products for hospital and home health care.
-
-
- View all 8 replies
-
-
Jeremy Johnson: STJ is not expensive, but it is getting close to fair value. Fair value stocks are still good to own... fair equity return is 8% a year.